Albert Einstein College of Medicine

Daniel R. Tishman To Chair Montefiore Medicine Trustee Board

Retrieved on: 
Wednesday, May 23, 2018

NEW YORK, May 23, 2018 /PRNewswire-USNewswire/ --Daniel R. Tishman has been named Chair of the Board of Trustees of Montefiore Medicine, the umbrella organization for Montefiore Health System and Albert Einstein College of Medicine .

Key Points: 
  • NEW YORK, May 23, 2018 /PRNewswire-USNewswire/ --Daniel R. Tishman has been named Chair of the Board of Trustees of Montefiore Medicine, the umbrella organization for Montefiore Health System and Albert Einstein College of Medicine .
  • Mr. Tishman is a longtime supporter of Montefiore Einstein and has been a member of the Board of Trustees for 15 years.
  • In 2011, Montefiore Einstein recognized Mr. Tishman and his wife, Sheryl, by building The Sheryl and Daniel R. Tishman Cognition Neurophysiology Laboratory at Einstein.
  • "It has been a true honor and privilege to serve as the Chair of the Board of Montefiore Medicine during a time of great growth and transformation, including the integration of Einstein into Montefiore," said David Tanner, who has transitioned from Chair to active Trustee.

Teen Depression, The Effects Of Sexting, And The Latest On Asthma: Just Some Of The Topics Explored In New Research From Montefiore-Einstein

Retrieved on: 
Saturday, May 5, 2018

Researchers for each of the above studies, as well as other Montefiore and Einstein faculty, are available to speak with media.

Key Points: 
  • Researchers for each of the above studies, as well as other Montefiore and Einstein faculty, are available to speak with media.
  • The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes.
  • Albert Einstein College of Medicine is one of the nation's premier centers for research, medical education and clinical investigation.
  • For more information, please visit www.einstein.yu.edu , read our blog , follow us on Twitter , like us on Facebook , and view us on YouTube .